Search results
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 4 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 4 days agoThe EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 4 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 7 days agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their ...
Wall Street Analysts Just Trimmed Price Target for Zscaler, Inc. (NASDAQ:ZS)
Insider Monkey via Yahoo Finance· 13 hours agoEuropean stocks started the day on May 21 with a slightly weaker note, marking a retreat from their...
Josh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more By Investing.com
Investing.com· 5 days agoJosh Gottheimer, the representative for New Jersey's 5th congressional district, has made a series...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoLike other early-stage biotech companies, Gyre has reported years of annual losses, though came in...
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace· 1 day agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. Companies with a strong reputation and...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 1 day agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 5 days ago/BioNTech SE. The investment firm, which owns approximately 6.8% of Arbutus, also called for a...